ChronicleBio
Chronicle Bio, Inc.
ChronicleBio brings together data, biology, and intelligence to reveal insights hidden within complex chronic disease. AI-powered drug discovery for neuroimmune conditions.
chroniclebio.com · Menlo Park, CA
Funding event
The round itself, as filedInferred stagePre-seed
Sold of offered$250K of $1.0M
Filed2026-11-12
Days since filing1
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- No
- Date of first sale
- 2026-10-28
Investors
No investors named: Form D does not list them
This round was amended. Amendment filing
Officers on the filing
Names and roles as filed; addresses are never stored- Rohit GuptaExecutive Officer · Director
- Rishi ReddyExecutive Officer · Director
- Jay SantoroDirector
- Fidji SimoDirector
Health flags
Three flags, each with the raw inputs behind it · as of 2026-11-13UndersubscribedNot flagged$15.4M of $16.0M sold0.5 months since first sale
Prior raiseFlaggedRaised $15.4M against a prior $2.2M$2.2M prior raise, filed 2025-10-15
AmendedNot flaggedD/A on 2026-11-12amount offered changed from $1.0M
Open roles
On the employer's own careers page · checked 2026-10-240
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
All filings
Every filing for this company, newest first, amendments includedAlso raised in Health & bio
Same sector, 28 days to 2026-11-15OrcosaSeries A · $6.0M of $11.5M · Ewing, NJQuietNanopathSeries B · $25.0M · Cambridge, MAQuiet
103 rounds in Health & bio in the 28 days to 2026-11-12, against 122 in the 28 days before.